Selection Criteria
- Demonstration of a creative approach to introducing and scaling new TB tools, emphasizing improved access and overcoming implementation barriers.
- Provision of clear evidence of scale-up, impact, and potential for lasting systemic change
The extent to which the prize money can contribute towards efforts to further scale-up or improve the new tool or approach
Selection Committee
The committee is composed of:
Mr Timur Abdullaev
Stop TB Partnership Board Member
Uzbekistan
Dr Kenneth Castro
Clinical Assistant Professor, Emory University School of Public Health
United States of America
Dr Paula Fujiwara
Scientific Director, International Union Against Tuberculosis and Lung Disease
France
Dr Mel Spigelman
President and CEO, Global Alliance for TB Drug Development
Co-Chair, Working Group on New TB Drugs
United States of America
Award Announcement and Ceremony
The 2024 Kochon Award ceremony will take place in Q1/Q2 2025.